Abstract
To optimize the physiochemical properties of 2-alkoxydihydrocinnamates as PPARα/γ dual agonist, a quantitative structure activity relationship, Hansch approach was made using combination of various thermodynamic, electronic and spatial descriptors. Several regression expressions are obtained using multiple linear regression analysis. The best QSAR model is further validated by leave-one-out cross validation method. Analyses of results from the present QSAR study suggest that for favorable dual PPARα/γ agonist activity electronic property of the substituents in hydrophobic tail phenyl ring plays a key role. The contribution of Hammett constant and dipole moment in the models deduced the importance of electron withdrawing substituents for dual activity. Additionally the study also indicates that bulky substituents in head acid moiety not confer selectivity towards the PPAR activity. Thus the QSAR study brings important structural insight to aid the design of dual PPARα/γ receptor agonist.
Keywords: QSAR, diabetes, hansch analysis, PPARα, PPARγ, hammett constant, dipole moment, heat of formation
Medicinal Chemistry
Title: Quantitative Structure Activity Analysis of 2-Alkoxydihydrocinnamates as PPARα /γ Dual Agonist
Volume: 4 Issue: 3
Author(s): P. Manoj Kumar, R. Hemalatha, S. C. Mahajan, C. Karthikeyan, N. S. Hari Narayana Moorthy and Piyush Trivedi
Affiliation:
Keywords: QSAR, diabetes, hansch analysis, PPARα, PPARγ, hammett constant, dipole moment, heat of formation
Abstract: To optimize the physiochemical properties of 2-alkoxydihydrocinnamates as PPARα/γ dual agonist, a quantitative structure activity relationship, Hansch approach was made using combination of various thermodynamic, electronic and spatial descriptors. Several regression expressions are obtained using multiple linear regression analysis. The best QSAR model is further validated by leave-one-out cross validation method. Analyses of results from the present QSAR study suggest that for favorable dual PPARα/γ agonist activity electronic property of the substituents in hydrophobic tail phenyl ring plays a key role. The contribution of Hammett constant and dipole moment in the models deduced the importance of electron withdrawing substituents for dual activity. Additionally the study also indicates that bulky substituents in head acid moiety not confer selectivity towards the PPAR activity. Thus the QSAR study brings important structural insight to aid the design of dual PPARα/γ receptor agonist.
Export Options
About this article
Cite this article as:
Kumar Manoj P., Hemalatha R., Mahajan C. S., Karthikeyan C., Hari Narayana Moorthy S. N. and Trivedi Piyush, Quantitative Structure Activity Analysis of 2-Alkoxydihydrocinnamates as PPARα /γ Dual Agonist, Medicinal Chemistry 2008; 4 (3) . https://dx.doi.org/10.2174/157340608784325188
DOI https://dx.doi.org/10.2174/157340608784325188 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Whole body vibration training improves walking performance of stroke patients with knee hyperextension: a randomized controlled pilot study
CNS & Neurological Disorders - Drug Targets Clinical and Rehabilitative Management of Retinitis Pigmentosa:Up-to-Date
Current Genomics MicroRNA-21: From Cancer to Cardiovascular Disease
Current Drug Targets Management Of Elderly Patients With Diffuse Large B-Cell Lymphomas
Anti-Cancer Agents in Medicinal Chemistry Atrial Fibrillation Recurrence: The Roles of Hypertension, Duration of Atrial Fibrillation Disease, and Prolonged Signal-Averaged P Wave Duration
Current Cardiology Reviews Statins and Left Ventricular Function
Current Pharmaceutical Design Egg Proteins and Peptides in Human Health-Chemistry, Bioactivity and Production
Current Pharmaceutical Design Neurogenic Drugs and Compounds
Recent Patents on CNS Drug Discovery (Discontinued) Nimodipine Loaded PLGA Nanoparticles: Formulation Optimization Using Factorial Design,Characterization and In Vitro Evaluation
Current Drug Delivery What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Current Molecular Medicine Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases
Current Pharmaceutical Design Meet Our Associate Editor
Current Cardiology Reviews The Potential Clinical Properties of Magnesium
Current Medicinal Chemistry Targeting CNS Transporters for Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design The Blood-brain Barrier and the Outer Blood-retina Barrier
Medicinal Chemistry Reviews - Online (Discontinued) Mast Cells: Pivotal Players in Cardiovascular Diseases
Current Cardiology Reviews A Co-Module Regulated by Therapeutic Drugs in a Molecular Subnetwork of Alzheimer’s Disease Identified on the Basis of Traditional Chinese Medicine and SAMP8 Mice
Current Alzheimer Research Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Factor VIII Levels are Associated with Ischemic Stroke, Stroke Subtypes and Neurological Worsening
Current Neurovascular Research Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets